IQVIA Set to Report Q4 Earnings: Analysts Eye Steady Growth Amid Sector Volatility
Clinical research giant IQVIA (NYSE: IQV) is scheduled to release its fourth-quarter financial results before Thursday's market open. With a track record of consistently topping revenue estimates, the report will be closely watched for signs of resilience in the life sciences tools and services sector.